Latest stock market podcasts

Between the BellsThe Bellcast
Between the Bells

From the helm: Alterity Therapeutics (ASX:ATH), CEO, David Stamler.

Bell Direct
March 20, 2026

In this episode of From the Helm, Grady chats with Alterity Therapeutics (ASX:ATH) CEO David Stamler, to discuss their neurodegenerative disorder treatment specifically targeting Multiple System Atrophy (MSA), a rare and aggressive disease affecting involuntary functions and motor control.

Morning Bell 30 September

Bell Direct
September 30, 2020

Morning Bell 29 September

Bell Direct
September 29, 2020

Morning Bell 28 September

Bell Direct
September 28, 2020

Weekly Wrap 25 September

Bell Direct
September 25, 2020

Morning Bell 24 September

Bell Direct
September 24, 2020

Morning Bell 23 September

Bell Direct
September 23, 2020

Morning bell 22 September

Bell Direct
September 22, 2020

Morning Bell 21 September

Bell Direct
September 21, 2020

Weekly Wrap 18 September

Bell Direct
September 18, 2020

Morning Bell 18 September

Bell Direct
September 18, 2020

Morning Bell 17 September

Bell Direct
September 17, 2020

From the helm: Westgold Resources’ (ASX:WGX) CEO, Debbie Fullarton

Bell Direct
September 16, 2020
  1. Pages:
  3. 1
  4. ...
  5. 127
  6. 128
  7. 129
  8. 130
  9. 131
  10. 132
  11. 133
  12. ...
  13. 147